BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 22414078)

  • 21. Depression: making the diagnosis and using SSRIs in the older patient.
    Reynolds CF
    Geriatrics; 1996 Oct; 51(10):28-34. PubMed ID: 8863755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vilazodone for the treatment of depression.
    Lindsey WT
    Ann Pharmacother; 2011 Jul; 45(7-8):946-53. PubMed ID: 21672888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant.
    Laughren TP; Gobburu J; Temple RJ; Unger EF; Bhattaram A; Dinh PV; Fossom L; Hung HM; Klimek V; Lee JE; Levin RL; Lindberg CY; Mathis M; Rosloff BN; Wang SJ; Wang Y; Yang P; Yu B; Zhang H; Zhang L; Zineh I
    J Clin Psychiatry; 2011 Sep; 72(9):1166-73. PubMed ID: 21951984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
    Meyer JH; Wilson AA; Sagrati S; Hussey D; Carella A; Potter WZ; Ginovart N; Spencer EP; Cheok A; Houle S
    Am J Psychiatry; 2004 May; 161(5):826-35. PubMed ID: 15121647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
    Menting JE; Honig A; Verhey FR; Hartmans M; Rozendaal N; de Vet HC; van Praag HM
    Int Clin Psychopharmacol; 1996 Sep; 11(3):165-75. PubMed ID: 8923095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic interactions of antidepressants.
    Richelson E
    J Clin Psychiatry; 1998; 59 Suppl 10():22-6. PubMed ID: 9720479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder.
    Guay DR
    Consult Pharm; 2012 Dec; 27(12):857-67. PubMed ID: 23229074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vilazodone: a new treatment option for major depressive disorder.
    Owen RT
    Drugs Today (Barc); 2011 Jul; 47(7):531-7. PubMed ID: 22013560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vilazodone for the treatment of major depressive disorder.
    Iranikhah M; Wensel TM; Thomason AR
    Pharmacotherapy; 2012 Oct; 32(10):958-65. PubMed ID: 23033234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
    Finley PR
    Ann Pharmacother; 1994 Dec; 28(12):1359-69. PubMed ID: 7696728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
    Taylor D
    Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
    van Harten J
    Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.
    Westin AA; Brekke M; Molden E; Skogvoll E; Spigset O
    PLoS One; 2017; 12(7):e0181082. PubMed ID: 28708853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopharmacologic treatment of adolescent depression.
    Lynch A; Glod CA; Fitzgerald F
    Arch Psychiatr Nurs; 2001 Feb; 15(1):41-7. PubMed ID: 11172238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Selective serotonin reuptake inhibitors--current knowledge].
    Dudek D; Zieba A; Siwek M; Wróbel A
    Psychiatr Pol; 2004; 38(3):507-24. PubMed ID: 15199659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vilazodone approved for major depression.
    Traynor K
    Am J Health Syst Pharm; 2011 Mar; 68(5):366. PubMed ID: 21330672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.